Par Health USA, LLC - NDC products
NDC labeler, manufacturer of drugs and pharmaceuticals
Products with assigned NDCs are displayed. Select the NDC to see product information. Select the Trade Name to see similar products.
Hide deleted NDCs:
| NDC | Trade Name | Labeler Name | Deleted | Deleted Date |
|---|---|---|---|---|
| 10370-0102 | Bupropion Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2025-02-28 |
| 10370-0101 | Bupropion Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2025-05-31 |
| 10370-0159 | Bupropion Hydrochloride | Par Pharmaceuticals, Inc. | Yes | No later than 2014-12-22 |
| 10370-0160 | Bupropion Hydrochloride | Par Pharmaceuticals, Inc. | Yes | No later than 2014-12-22 |
| 10370-0161 | Bupropion Hydrochloride | Par Pharmaceuticals, Inc. | Yes | No later than 2014-12-22 |
| 10370-0204 | Bupropion Hydrochloride | Anchen Pharmaceuticals, Inc. | Yes | No later than 2017-12-29 |
| 10370-0107 | Ciprofloxacin Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2017-12-29 |
| 10370-0108 | Ciprofloxacin Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2017-12-29 |
| 10370-0302 | Clonidine Hydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
| 10370-0257 | Clonidine Hydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-04-30 |
| 10370-0170 | Darifenacin Hydrobromide Extended-Release | Par Pharmaceutical, Inc. | Yes | 2021-02-28 |
| 10370-0171 | Darifenacin Hydrobromide Extended-Release | Par Pharmaceutical, Inc. | Yes | 2021-02-28 |
| 10370-0832 | Diltiazem Hydrochloride Extended-Release | Endo USA, Inc. | Yes | No later than 2026-09-17 |
| 10370-0831 | Diltiazem Hydrochloride Extended-Release | Endo USA, Inc. | Yes | No later than 2026-09-17 |
| 10370-0830 | Diltiazem Hydrochloride Extended-Release | Endo USA, Inc. | Yes | No later than 2026-09-17 |
| 10370-0829 | Diltiazem Hydrochloride Extended-Release | Endo USA, Inc. | Yes | No later than 2026-09-17 |
| 10370-0510 | Divalproex Sodium Extended Release | Par Pharmaceutical, Inc. | Yes | 2021-06-30 |
| 10370-0511 | Divalproex Sodium Extended Release | Par Pharmaceutical, Inc. | Yes | 2021-01-31 |
| 10370-0280 | Dutasteride and Tamsulosin Hydrochloride | Endo USA, Inc. | Yes | No later than 2026-09-17 |
| 10370-0209 | Fenofibric Acid Delayed-Release | Par Pharmaceutical, Inc. | Yes | 2021-02-28 |
| 10370-0210 | Fenofibric Acid Delayed-Release | Par Pharmaceutical, Inc. | Yes | 2021-07-31 |
| 10370-0175 | Fluvoxamine Maleate | Par Health USA, LLC | No | |
| 10370-0176 | Fluvoxamine Maleate | Par Health USA, LLC | No | |
| 10370-0746 | Glipizide | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
| 10370-0745 | Glipizide | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
| 10370-0191 | Glipizide ER | Par Pharmaceuticals, Inc. | Yes | 2019-01-31 |
| 10370-0190 | Glipizide ER | Par Pharmaceuticals, Inc. | Yes | 2019-01-31 |
| 10370-0536 | Guanfacine Extended-Release | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
| 10370-0533 | Guanfacine Extended-Release | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
| 10370-0534 | Guanfacine Extended-Release | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
| 10370-0538 | Guanfacine Extended-Release | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
| 10370-0334 | Lamotrigine Extended-Release | Par Health USA, LLC | No | |
| 10370-0256 | Lamotrigine Extended-Release | Par Health USA, LLC | No | |
| 10370-0207 | Lamotrigine Extended-Release | Par Health USA, LLC | No | |
| 10370-0208 | Lamotrigine Extended-Release | Par Health USA, LLC | No | |
| 10370-0214 | levetiracetam extended-release | Par Pharmaceutical, Inc. | Yes | No later than 2022-09-29 |
| 10370-0195 | levetiracetam extended-release | Par Pharmaceutical, Inc. | Yes | No later than 2022-09-29 |
| 10370-0266 | Lubiprostone | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
| 10370-0267 | Lubiprostone | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
| 10370-0349 | Memantine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2023-06-30 |
| 10370-0348 | Memantine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2023-06-30 |
| 10370-0346 | Memantine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2023-06-30 |
| 10370-0347 | Memantine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2023-06-30 |
| 10370-0677 | Nifedipine | Par Pharmaceutical, Inc. | Yes | 2019-11-30 |
| 10370-0678 | Nifedipine | Par Pharmaceutical, Inc. | Yes | 2019-11-30 |
| 10370-0679 | Nifedipine | Par Pharmaceutical, Inc. | Yes | 2019-11-30 |
| 10370-0390 | Nifedipine Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2017-12-29 |
| 10370-0391 | Nifedipine Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2017-12-29 |
| 10370-0392 | Nifedipine Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2017-12-29 |
| 10370-0219 | Potassium Chloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2019-09-30 |
| 10370-0220 | Potassium Chloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2020-01-31 |
| 10370-0255 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
| 10370-0306 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-01-31 |
| 10370-0305 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-07-31 |
| 10370-0251 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2022-10-31 |
| 10370-0252 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2022-07-31 |
| 10370-0253 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-09-30 |
| 10370-0254 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-01-31 |
| 10370-0351 | Sitagliptin and Metformin hydrochloride | Par Health USA, LLC | No | |
| 10370-0318 | Sitagliptin and Metformin hydrochloride | Par Health USA, LLC | No | |
| 10370-0317 | Sitagliptin and Metformin hydrochloride | Par Health USA, LLC | No | |
| 10370-0169 | Tamsulosin Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2021-12-22 |
| 10370-0367 | Topiramate | Par Health USA, LLC | No | |
| 10370-0368 | Topiramate | Par Health USA, LLC | No | |
| 10370-0366 | Topiramate | Par Health USA, LLC | No | |
| 10370-0365 | Topiramate | Par Health USA, LLC | No | |
| 10370-0221 | Tramadol Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2022-01-31 |
| 10370-0222 | Tramadol Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2022-01-31 |
| 10370-0223 | Tramadol Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2022-01-31 |
| 10370-0268 | Tretinoin | Par Health USA, LLC | No | |
| 10370-0117 | Zolpidem Tartrate Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-06-30 |
| 10370-0116 | Zolpidem Tartrate Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-07-31 |
Thank you for choosing Find-A-Code, please Sign In to remove ads.

Quick, Current, Complete - www.findacode.com